About Steven Basta
Form D filings for DermBiont from 2020 to 2024 list Steven Basta as director.
Steven Basta first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Steven Basta in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Steven Basta works with at each company, as listed on that company's latest Form D.
DermBiont, Inc. · Form D/A, Nov 13, 2024
DY
Daniel Yadegar
Director
KB
Karl Beutner
Chief Executive Officer and director
NE
Nichola Eliovits
Executive officer and director
MD
Max Dawson
Executive officer
WR
Wilder Ramsey
Director